|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/67 |
| (11) | Patento numeris | 3359670 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16782372.3 |
| Europos patento paraiškos padavimo data | 2016-10-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-08-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-05-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/055582 |
| Data | 2016-10-05 |
| (87) | Numeris | WO 2017/062513 |
| Data | 2017-04-13 |
| (30) | Numeris | Data | Šalis |
| 201562237462 P | 2015-10-05 | US | |
| 201662317268 P | 2016-04-01 | US | |
| 201662317271 P | 2016-04-01 | US | |
| 201662317366 P | 2016-04-01 | US | |
| 201662338388 P | 2016-05-18 | US | |
| 201662338385 P | 2016-05-18 | US | |
| 201662338386 P | 2016-05-18 | US | |
| 201662350149 P | 2016-06-14 | US |
| (72) |
HOGE, Stephen, US
CHAKRABORTY, Tirtha, US
BESIN, Gilles, US
JAIN, Ruchi, US
|
| (73) |
Modernatx, Inc.,
200 Technology Square, Cambridge, MA 02139,
US
|
| (54) | METHODS FOR THERAPEUTIC ADMINISTRATION OF MESSENGER RIBONUCLEIC ACID DRUGS |
| METHODS FOR THERAPEUTIC ADMINISTRATION OF MESSENGER RIBONUCLEIC ACID DRUGS |